BIAGINI, AGNESE
 Distribuzione geografica
Continente #
NA - Nord America 1.463
EU - Europa 1.246
AS - Asia 617
SA - Sud America 71
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.451
Nazione #
US - Stati Uniti d'America 1.424
DE - Germania 607
CN - Cina 214
GB - Regno Unito 176
SG - Singapore 173
SE - Svezia 163
HK - Hong Kong 97
IT - Italia 88
BR - Brasile 58
BG - Bulgaria 57
RU - Federazione Russa 37
CA - Canada 36
CI - Costa d'Avorio 35
FR - Francia 31
VN - Vietnam 30
IN - India 29
AT - Austria 26
TR - Turchia 25
FI - Finlandia 24
SN - Senegal 15
JP - Giappone 12
BE - Belgio 10
NL - Olanda 10
AR - Argentina 7
PK - Pakistan 5
UA - Ucraina 5
PL - Polonia 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
ES - Italia 3
IR - Iran 3
MY - Malesia 3
BD - Bangladesh 2
CO - Colombia 2
IQ - Iraq 2
NP - Nepal 2
PH - Filippine 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
MX - Messico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 3.451
Città #
Ashburn 188
Chandler 108
Santa Clara 105
Woodbridge 100
Fairfield 97
Hong Kong 96
Ann Arbor 92
Dallas 82
Singapore 75
London 60
Beijing 58
Sofia 57
Shanghai 47
New York 45
Los Angeles 42
Wilmington 41
Houston 39
Seattle 36
Abidjan 35
Cambridge 34
Ottawa 26
Princeton 25
Boulder 23
Vienna 23
Boardman 22
Bremen 21
Des Moines 20
Lawrence 20
Medford 18
Dearborn 17
Florence 16
Dakar 15
Frankfurt am Main 14
Serra 13
Istanbul 11
Munich 11
Nanjing 11
Nürnberg 11
Brussels 10
Düsseldorf 10
Izmir 10
Tokyo 10
Redondo Beach 9
Changsha 8
Columbus 8
Council Bluffs 8
Helsinki 8
Philadelphia 8
Buffalo 6
Dong Ket 6
Jiaxing 6
Lancaster 6
Wuhan 6
City of London 5
Falkenstein 5
Guangzhou 5
Ho Chi Minh City 5
San Diego 5
San Francisco 5
City of Westminster 4
Fuzhou 4
Jacksonville 4
Nanchang 4
Pisa 4
Quanzhou 4
Bengaluru 3
Boydton 3
Canary Wharf 3
Chengdu 3
Chicago 3
Denver 3
Hangzhou 3
Hanoi 3
Lahore 3
Lucca 3
Ningbo 3
Ogden 3
Palermo 3
Pune 3
Riyadh 3
São Paulo 3
Toronto 3
Washington 3
Amsterdam 2
Baotou 2
Belo Horizonte 2
Brooklyn 2
Crewe 2
Curitiba 2
Elâzığ 2
Hortolândia 2
Karachi 2
Kunming 2
Lauterbourg 2
Mariano Moreno 2
Montreal 2
Mumbai 2
Nutley 2
Redmond 2
Redwood City 2
Totale 2.015
Nome #
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 302
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 232
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 227
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 218
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE 195
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 191
Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico. 184
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 181
Il carcinoma tiroideo: nuove prospettive terapeutiche. 168
null 146
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) 142
Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience 121
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) 109
null 107
Significato prognostico della mutazione di BRAF in pazienti affetti da carcinoma papillare della tiroide con follow-up di 20 anni. 107
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. 106
null 105
Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor. 104
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study 94
. Utilità della ricerca della mutazione di BRAF nel tumore primitivo di pazienti affetti da carcinoma papillare della tiroide a basso rischio. 93
null 84
Il carcinoma della tiroide 74
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. 74
Ret Oncogene and Thyroid Carcinoma 63
How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level. 57
Totale 3.484
Categoria #
all - tutte 9.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 4 3 13 9 6 9 4 19
2021/2022266 10 10 2 26 59 33 11 7 13 9 13 73
2022/2023440 59 77 38 35 34 42 8 29 82 1 31 4
2023/2024175 16 11 15 0 21 46 18 6 3 9 9 21
2024/2025779 17 34 17 45 93 79 28 33 89 104 54 186
2025/2026334 85 77 87 51 34 0 0 0 0 0 0 0
Totale 3.484